Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06112093 · ClinicalTrials.gov registry record · Phase 1

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

A Phase 1 study of Mild Traumatic Brain Injury and Headache, sponsored by State University of New York - Upstate Medical University.

Recruiting
Registry status
Phase 1
Development phase
60
Enrollment target
1
Study location

NCT06112093: Recruiting Phase 1 study of Mild Traumatic Brain Injury and Headache, sponsored by State University of New York - Upstate Medical University.

NCT06112093 is a Phase 1 study of Mild Traumatic Brain Injury and Headache that is actively recruiting participants, run by State University of New York - Upstate Medical University. The registered enrollment target is 60 participants, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06112093, a Phase 1 study of Mild Traumatic Brain Injury and Headache, is actively recruiting participants, sponsored by State University of New York - Upstate Medical University.

RECRUITING
Registry status
Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.

Primary Outcome

Composite headache score will be calculated as average intensity (NRS) × average frequency (episode/day) × average duration (hours/episode).

Conditions Studied

Mild Traumatic Brain Injury Headache Brain Concussion Post-Concussion Symptoms

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation
  • DEVICE Sham Repetitive Transcranial Magnetic Stimulation

Study Locations (1)

New York

  • SUNY Upstate Medical University - Syracuse

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-10-23
Est. Completion 2027-10-23
Phase Phase 1
State University of New York - Upstate Medical University

113 total trials

What NCT06112093 shows while recruiting

NCT06112093 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower).

The record links to 4 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation is the first listed.

NCT06112093 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06112093 about?

NCT06112093 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches". This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effect...

What is the current status of trial NCT06112093?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2023-10-23. Estimated completion is 2027-10-23.

What conditions does trial NCT06112093 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Headache, Brain Concussion, Post-Concussion Symptoms.

What interventions are being tested in trial NCT06112093?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE), Sham Repetitive Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06112093?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06112093 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06112093's enrollment target sits among peer trials

60 29th of 43 higher than 12 of 43 other Mild Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06112093

Source: ClinicalTrials.gov NCT06112093, the US trial registry maintained by the National Library of Medicine. NCT06112093 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.